Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Pomalidomide
Drug ID BADD_D01798
Description Pomalidomide, an analogue of thalidomide, is an immunomodulatory antineoplastic agent. FDA approved on February 8, 2013.
Indications and Usage Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Marketing Status approved
ATC Code L04AX06
DrugBank ID DB08910
KEGG ID D08976
MeSH ID C467566
PubChem ID 134780
TTD Drug ID D0A3ZU
NDC Product Code 65015-893; 17337-0068; 63069-404; 68554-0092; 70225-1106; 59572-501; 59572-502; 55111-989; 68554-0091; 82245-0108; 63069-402; 42973-232; 54893-0038; 59572-503; 59572-504; 63069-403
UNII D2UX06XLB5
Synonyms pomalidomide | CC-4047 | CC 4047 | CC4047 | Imnovid | Pomalyst | actimid
Chemical Information
Molecular Formula C13H11N3O4
CAS Registry Number 19171-19-8
SMILES C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blister23.03.01.001; 12.01.06.002--Not Available
Blood creatinine increased13.13.01.004--
Body temperature increased13.15.01.001--Not Available
Bone disorder15.02.04.0040.004436%Not Available
Bone neoplasm15.09.02.001; 16.29.01.0010.000241%Not Available
Bone pain15.02.01.0010.029006%
Breast mass21.05.04.0020.001591%Not Available
Breast swelling21.05.05.0080.000530%Not Available
Breath odour07.01.06.0020.000241%Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Bronchospasm22.03.01.004; 10.01.03.012--
Bursitis12.04.03.010; 15.04.01.0010.002411%Not Available
Calculus bladder20.04.03.0010.000241%Not Available
Cardiac amyloidosis02.04.01.013; 10.02.05.0020.000844%Not Available
Cardiac arrest02.03.04.001--
Cardiac failure02.05.01.001--
Cardiac failure congestive02.05.01.0020.010247%Not Available
Cataract06.06.01.0010.012297%
Cellulitis23.11.02.004; 11.02.01.001--Not Available
Cerebral haemorrhage24.07.04.001; 17.08.01.003--Not Available
Cerebral thrombosis24.01.04.003; 17.08.01.0060.000482%Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Change of bowel habit07.02.03.0020.000651%Not Available
Chills15.05.03.016; 08.01.09.001--
Chronic obstructive pulmonary disease22.03.01.0070.007016%Not Available
Clostridium difficile colitis07.19.01.004; 11.02.02.004--Not Available
Clumsiness17.01.02.0050.000820%Not Available
Colitis ischaemic24.04.08.012; 07.08.01.0040.001447%Not Available
Compression fracture15.08.02.004; 12.04.02.008--Not Available
Confusional state19.13.01.001; 17.02.03.005--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 16 Pages